New lung cancer treatment options have emerged, and several groups are exploring treatment strategies that omit chemotherapy for locally advanced NSCLC.
Nitin Ohri, MD, MS
Advertisement
Nitin Ohri, MD, MS, is a professor of radiation oncology at Montefiore Einstein Comprehensive Cancer Center
Articles by Nitin Ohri, MD, MS
The idea to provide wearable devices to my patients first came to me 6 years ago at a charity spinning event.
Nitin Ohri, MD, discusses the role of chemoradiation therapy in locally advanced non–small cell lung cancer.
Advertisement
Latest Updated Articles
Dr. Ohri on the Role of Chemoradiation in Locally Advanced NSCLCPublished: January 26th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5